Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 USD | -0.29% | -5.65% | -7.75% |
May. 30 | Transcript : Roivant Sciences Ltd., Q4 2024 Earnings Call, May 30, 2024 | |
May. 30 | Roivant Sciences' Fiscal Q4 Net Loss Widens, Revenue Rises | MT |
Chart calendar Roivant Sciences Ltd.
Upcoming events on Roivant Sciences Ltd.
Past events on Roivant Sciences Ltd.
2024-05-30 08:00 am | Q4 2023 Earnings Call |
2024-05-30 07:00 am | Q4 2023 Earnings Release |
2024-05-20 09:00 am | H.C. Wainwright BioConnect Investor Conference |
2024-04-07 | Investor Meeting |
2024-04-02 08:00 am | NEPTUNE Phase 2 Study Results Call |
2024-03-11 01:20 pm | Leerink Partners Global Biopharma Conference |
2024-02-13 08:00 am | Q3 2023 Earnings Call |
2024-02-13 07:00 am | Q3 2023 Earnings Release |
2024-02-07 02:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
2024-01-08 05:15 pm | JPMorgan Healthcare Conference |
2023-11-30 11:00 am | Piper Sandler Healthcare Conference |
2023-11-29 12:55 pm | Evercore ISI HealthCONx Conference |
2023-11-15 08:30 am | Jefferies London Healthcare Conference |
2023-11-13 08:00 am | Q2 2023 Earnings Call |
2023-11-13 07:00 am | Q2 2023 Earnings Release |
2023-11-07 04:30 pm | Guggenheim Inflammation, Neurology, & Immunology Conference |
2023-10-23 08:00 am | Acquisition of Telavant Holdings, Inc by Roivant Sciences Ltd Call |
2023-09-27 11:30 am | Cantor Global Healthcare Conference |
2023-09-25 | Investor Meeting |
2023-09-12 05:30 am | Annual General Meeting |
Annual results
Fiscal Period | March | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 55,3 52,6 5.08% | 61,3 52,3 17.2% | 125 662 -81.14% |
EBITDA Million USD | Released Forecast Spread | 0,00 | -1 346 -1 304 -3.16% | -1 156 -1 190 2.8% | -1 084 -1 071 -1.28% |
EBIT Million USD | Released Forecast Spread | 0,00 | -1 352 -1 181 -14.47% | -1 175 -1 170 -0.41% | -1 106 1 608 -168.79% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -924 -864 -6.97% | -1 225 -1 313 6.71% | 4 253 4 176 1.87% |
Net income Million USD | Released Forecast Spread | -809 | -845 -740 -14.23% | -1 009 -1 216 16.99% | 4 349 4 261 2.07% |
EPS USD | Released Forecast Spread | -3,76 | -1,26 -1,24 -1.34% | -1,42 -1,71 17.02% | 5,23 5,18 0.99% |
Announcement Date | 01/07/21 | 28/06/22 | 28/06/23 | 30/05/24 |
Quarterly results
Fiscal Period | Maart | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 24,3 9,87 146.72% | 9,22 11,6 -20.3% | 4,32 7,18 -39.83% | 12,5 5,70 119.85% | 17,1 14,8 15.34% | 27,4 18,2 50.4% | 21,6 24,5 -11.69% | 37,1 27,1 36.82% | 37,1 29,8 24.53% | 28,9 30,9 -6.51% | 53,3 | 33,3 | 37,0 | 41,0 |
EBITDA Million USD | Released Forecast Spread | -281 -291 3.52% | -378 -291 -29.92% | -228 -288 20.76% | -271 -284 4.56% | -271 -264 -2.5% | -282 -265 -6.51% | -261 -240 -8.52% | |||||||
EBIT Million USD | Released Forecast Spread | -246 -177 -38.73% | -267 -240 -10.95% | -282 -250 -13.14% | -281 -293 4.13% | -378 -309 -22.4% | -234 -285 17.76% | -276 -258 -7.28% | -276 -257 -7.63% | 5 061 -267 1992.11% | -266 -285 6.65% | -268 | -271 | -273 | -260 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -306 -175 -75.31% | -291 -247 -17.8% | -350 -243 -43.86% | -314 -299 -5.05% | -382 -320 -19.46% | -179 -309 41.96% | -326 -249 -30.78% | -327 -249 -31.46% | 5 098 -279 1929.33% | -191 -276 30.57% | -201 | -211 | -221 | -232 |
Net income Million USD | Released Forecast Spread | -285 -163 -74.87% | -270 -206 -30.98% | -332 -222 -49.66% | -292 -280 -4.2% | -352 -294 -19.63% | -33,6 -280 88.01% | -292 -235 -24.3% | -304 -225 -34.98% | 5 096 -255 2094.89% | -151 -248 39.06% | -172 | -209 | -220 | -235 |
EPS USD | Released Forecast Spread | -0,41 -0,24 -70.83% | -0,39 -0,30 -30% | -0,48 -0,32 -48.02% | -0,42 -0,41 -1.76% | -0,49 -0,40 -22.69% | -0,05 -0,38 86.8% | -0,38 -0,31 -24.18% | -0,40 -0,31 -30.84% | 6,03 0,49 1140.1% | -0,19 -0,30 35.75% | -0,30 | -0,32 | -0,34 | -0,33 |
Announcement Date | 14/02/22 | 28/06/22 | 15/08/22 | 14/11/22 | 13/02/23 | 28/06/23 | 14/08/23 | 13/11/23 | 13/02/24 | 30/05/24 | - | - | - | - |
Past sector events for Roivant Sciences Ltd.
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ROIV Stock
- Calendar Roivant Sciences Ltd.